 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
4-3-2017
Insider Buy |
David Ian Johnson
President and CEO |
$0.40
CAGR »
|
$100,000.00
250,000 shares |
4-3-2017
Insider Buy |
Pellegrino Pionati
See Remarks |
$0.40
CAGR »
|
$20,000.00
50,000 shares |
4-3-2017
Insider Buy |
Joseph M. Leone
Director |
$0.40
CAGR »
|
$10,000.00
25,000 shares |
4-3-2017
Insider Buy |
Bradford Barton
Chief Operating Officer |
$0.40
CAGR »
|
$30,000.00
75,000 shares |
4-3-2017
Insider Buy |
Mark T. Wagner
Director |
$0.40
CAGR »
|
$25,000.00
62,500 shares |
2-27-2017
Insider Buy |
Corp /DE/ Celgene
>10% Owner |
$0.50
CAGR »
|
$2,000,000.00
4,000,000 shares |
2-27-2017
Insider Buy |
Jerome B. Zeldis
Director |
$0.50
CAGR »
|
$200,000.00
400,000 shares |
11-6-2015
Insider Buy |
Jeffrey Sklar
Director |
$2.95
CAGR »
|
$4,425.00
1,500 shares |
11-9-2015
Insider Buy |
Brian M. Posner
Chief Financial Officer |
$3.04
CAGR »
|
$15,200.00
5,000 shares |
11-6-2015
Insider Buy |
Bradford Barton
Chief Operating Officer |
$2.97
CAGR »
|
$14,850.00
5,000 shares |
11-6-2015
Insider Buy |
Pellegrino Pionati
Chief Strategy & Marketing Off |
$2.95
CAGR »
|
$29,500.00
10,000 shares |
11-6-2015
Insider Buy |
Jerome B. Zeldis
Director |
$2.91
CAGR »
|
$40,740.00
14,000 shares |
11-6-2015
Insider Buy |
Mark T. Wagner
Director |
$2.88
CAGR »
|
$23,040.00
8,000 shares |
11-6-2015
Insider Buy |
Joseph M. Leone
Director |
$2.78
CAGR »
|
$9,730.00
3,500 shares |
11-6-2015
Insider Buy |
David Ian Johnson
President and CEO |
$2.92
CAGR »
|
$25,258.00
8,650 shares |
8-10-2015
Insider Buy |
Brian M. Posner
Chief Financial Officer |
$5.02
CAGR »
|
$12,550.00
2,500 shares |
6-8-2015
Insider Buy |
Bradford Barton
Chief Operating Officer |
$5.25
CAGR »
|
$15,735.00
3,000 shares |
5-27-2015
Insider Buy |
David Ian Johnson
President and CEO |
$4.65
CAGR »
|
$46,458.00
10,000 shares |
5-20-2015
Insider Buy |
Brian M. Posner
Chief Financial Officer |
$4.34
CAGR »
|
$10,850.00
2,500 shares |
5-4-2015
Insider Buy |
Corp /DE/ Celgene
>10% Owner |
$4.55
CAGR »
|
$2,999,997.00
659,340 shares |
9-15-2014
Insider Buy |
Brian M. Posner
Chief Financial Officer |
$4.94
CAGR »
|
$9,880.00
2,000 shares |
5-13-2014
Insider Buy |
Brian M. Posner
Chief Financial Officer |
$6.92
CAGR »
|
$20,760.00
3,000 shares |
4-14-2014
Insider Buy |
Corp /DE/ Celgene
>10% Owner |
$7.00
CAGR »
|
$5,000,002.00
714,286 shares |
5-21-2013
Insider Buy |
Kenneth L. Londoner
Director |
$0.07
CAGR »
|
$15,059.00
219,500 shares |
Also See: Institutional Holders of ALQA
Also See: SEC filings
Below we present the annualized performance delivered by ALQA stock since 4-3-2017 (the date of the most recent
insider purchase). The performance of the investment from the time ALQA insider buying occurred is the ultimate
test of whether insiders were right about ALQA being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/04/2017 |
|
| End date: |
05/03/2019 |
|
| Start price/share: |
$4.70 |
|
| End price/share: |
$2.69 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-42.77% |
|
| Average Annual Total Return: |
-23.54% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,722.78 |
|
| Years: |
2.08 |
|
ALQA Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent ALQA insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ALQA
|
|
Free ALQA Email Alerts:
